Medicinal use of cannabis and cannabinoids in older adults: Where is the evidence?

Journal of the American Geriatrics Society

Volumn 62, Issue 2, 2014, Pages 410-411

  Ahmed, Amir I A ^a,b   Van Den Elsen, Geke A H ^b   Van Der Marck, Marjolein A ^b   Olde Rikkert, Marcel G M ^b  

^a Vincent Van Gogh ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CACHEXIA; CANNABINOIDS; CANNABIS; HUMANS; MIDDLE AGED; MUSCLE SPASTICITY; PHYTOTHERAPY; YOUNG ADULT;

EID: 84894131719     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12661     Document Type: Letter

References (13)

1. Pertwee RG,. Cannabinoid pharmacology: The first 66 years. Br J Pharmacol 2006; 147 (Suppl 1): S163-S171.
2. Hazekamp A, Ware MA, Muller-Vahl KR, et al. The medicinal use of cannabis and cannabinoids-an international cross-sectional survey on administration forms. J Psychoactive Drugs 2013; 45: 199-210.
3. Hazekamp A, Heerdink ER,. The prevalence and incidence of medicinal cannabis on prescription in the Netherlands. Eur J Clin Pharmacol 2013; 69: 1575-1580.
4. Adler JN, Colbert JA,. Clinical decisions. Medicinal use of marijuana-polling results. N Engl J Med 2013; 368: e30.
5. Bostwick JM, Reisfield GM, DuPont RL,. Clinical decisions. Medicinal use of marijuana. N Engl J Med 2013; 368: 866-868.
6. Frytak S, Moertel CG, O'Fallon JR, et al. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med 1979; 91: 825-830.
7. Sallan SE, Cronin C, Zelen M, et al. Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med 1980; 302: 135-138.
8. Campbell FA, Tramèr MR, Carroll D, et al. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review BMJ 2001; 323: 13-16.
9. Lynch ME, Campbell F,. Cannabinoids for treatment of chronic non-cancer pain: A systematic review of randomized trials. Br J Clin Pharmacol 2011; 72: 735-744.
10. Corsonello A, Pedone C, Incalzi RA,. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010; 17: 571-584.
11. Volicer L, Stelly M, Morris J, et al. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. Int J Geriatr Psychiatry 1997; 12: 913-919.
12. Walther S, Schüpbach B, Seifritz E, et al. Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia. J Clin Psychopharmacol 2011; 31: 256-258.
13. Carroll CB, Bain PG, Teare L, et al. Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study. Neurology 2004; 63: 1245-1250.